A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology

20250 citationsJournal Articlegold Open Access

Authors

L. P. Gebhardt · Pfizer (United States)

Molica Abel · Pfizer (United States)

Jing Zhou · Pfizer (United States)

A Vogt · Pfizer (United States)

Bo Hee Shin · Pfizer (United States)

Sarah L. Herrick Wagman · Pfizer (United States)

Ana Luísa Santos ·

Abstract

This new production platform was proven to be robust and could be applied for the routine production of antibodies of sufficient quality and quantity in support of cell-based assays and biophysical characterization.

Topics & Keywords

Viral Infectious Diseases and Gene Expression in Insects Monoclonal and Polyclonal Antibodies Research Protein purification and stability

Publication Details

Published in: Antibodies

Volume 14, Issue 4, pp. 87-87

DOI: 10.3390/antib14040087

Field-Weighted Citation Impact: 0.00

Command Palette

A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology

Authors

Abstract

Topics & Keywords

Publication Details